(Last updated: December 16, 2021)
Appendix B: Panel Roster and Financial Disclosures
Pharmacology
| Member | Institution | Financial Disclosure | |
|---|---|---|---|
| Company | Relationship | ||
| Kelly Dooley | Johns Hopkins University, School of Medicine | None | N/A |
| Jomy George | National Institutes of Health | None | N/A |
| Emily Heil | University of Maryland, School of Pharmacy | Lexi-Comp | Consultant |
| Safia Kuriakose | National Institutes of Health | None | N/A |
| Alice Pau* | National Institutes of Health | None | N/A |
| Charles Peloquin | University of Florida, College of Pharmacy | None | N/A |
| Jason Schafer | Jefferson College of Pharmacy, Thomas Jefferson University | Merck ViiV Healthcare |
Scientific Advisory Board |
| Merck Gilead Sciences |
Research Support (paid to institution) | ||
| * Group lead Note: Members are required to update disclosures annually and to notify guideline staff of any relevant changes in status during the interim. |
|||
Download Guidelines
- Section OnlyPDF (200.36 KB)
- Full GuidelinePDF (3.78 MB)
- Tables OnlyPDF (481.21 KB)